COSRX Achieves Double-Digit Growth in Q1 2026 After Global Restructuring
Creatrip Team
a month ago
Dermocosmetic brand COSRX continued momentum from late 2025 into Q1 2026, posting double-digit growth and marking a clear turnaround. The company said May delivered its highest monthly sales of the year after intensive structural improvements — streamlining global distribution and logistics and adjusting pricing — which restored overseas growth. Since its 2013 founding, COSRX has targeted the global beauty market with differentiated products, and recent wholesale and logistics reforms helped the brand recover sales. Strong performance came from North America and Europe: in the U.S., sales rose not only from the established “Snail” line but especially from new peptide-focused releases like the best-selling “Peptide Eye Patch” on TikTok Shop; in Europe, the “Ultra-Light Invisible Sun Serum” reached #1 in the sunscreen category on Amazon UK and Germany, outperforming long-standing global beauty firms. COSRX expects continued growth as peptide and sun-serum lines broaden its revenue base beyond the Snail line.
